Pegawin Tablet

Przegląd produktu

About Pegawin Tablet

Pegawin Tablet is a medication containing the active ingredient Benfotiamine, classified as Thiamine analogue. Benfotiamine is a synthetic, fat-soluble, S-acyl derivative of thiamine that is approved in some countries as a medication or dietary supplement to treat diabetic sensorimotor polyneuropathy. Benfotiamine was developed in the late 1950s in Japan.

Key Benefits & Uses

• Used for: Benfotiamine is a synthetic, fat-soluble, S-acyl derivative of thiamine that is approved in some countries as a medication or dietary supplement to.
• Used for: Benfotiamine was developed in the late 1950s in Japan
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Benfotiamine, the active ingredient in Pegawin Tablet, belongs to the Thiamine analogue class. Its clinical use follows the authorised labelling for Benfotiamine-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Pegawin Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Pegawin Tablet for extended periods without medical advice.